CTSU Program for the assessment of Clinical Cancer Tests (PACCT-1): Trial Assessing Individualized Options for Treatment: The TRAIL ORx Trial

Cancer - Breast
  1. Patients must be 18 to 75 years of age.
  2. ER and/or PR positive.
  3. Tumor size 1.1 - 5.0 cm.
  4. Must be HER2/neu negative. Tissue specimen must be available.
  5. Mandatory prior surgery.
  6. No prior chemotherapy or radiation
Tiffany Pearce